Bill C-265 (45-1)

An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)

Sponsor: Marcus Powlowski | Type: Private Member’s Bill | Introduced: 2026-03-11 | Royal Assent: N/A

healthcare

Same data, different priorities. Click a model to see how this bill scores under different value systems.